Congratulations

Baum Hedlund Honored in Lawdragon 500 Leading Plaintiff Consumer Lawyers 2022

Baum Hedlund senior shareholders Michael L. Baum, R. Brent Wisner, and Bijan Esfandiari have been honored in the 2022 Lawdragon 500 Leading Plaintiff Consumer Lawyers 2022 edition. Lawdragon honored the three attorneys for their outstanding legal work on complex personal injury cases in Los Angeles, California, and across the country.

Michael L. Baum is Baum Hedlund’s president and managing shareholder who oversees all of the firm’s class actions and mass tort litigation, including the Zantac cancer litigation and the baby food litigation. He and senior shareholder Bijan Esfandiari are currently spearheading the Gardasil HPV vaccine litigation against Merck. Previous mass torts include pharmaceutical drugs, medical devices, and consumer products like Monsanto’s Roundup. Lawdragon 500 has recognized Attorney Baum for four consecutive years (2019-2022). Read Michael Baum’s Lawdragon Lawyer Limelight article.

R. Brent Wisner is Baum Hedlund’s vice president, a senior shareholder and one of the firm’s lead trial attorneys. Attorney Wisner gained widespread acclaim for his work in the Monsanto Roundup litigation, where he served as co-lead trial counsel in two of the first three cases to go before juries. These trials culminated in jury verdicts worth over $2.3 billion and helped pave the way for settlements with Bayer worth roughly $11 billion. Mr. Wisner is currently Co-Lead Plaintiffs’ Liaison Counsel for the Ranitidine Product Cases, also known as the Ranitidine (Zantac) Judicial Council Coordinated Proceedings (JCCP 5150) in California. Lawdragon 500 has recognized Attorney Wisner for four consecutive years (2019-2022).

Bijan Esfandiari is a pharmaceutical product liability litigation attorney and senior shareholder at Baum Hedlund. He has worked as lead counsel on many of the firm’s cutting-edge major pharmaceutical and medical device cases. His skilled legal advocacy has helped thousands of clients secure full and fair compensation. Attorney Esfandiari’s successes have included many precedent-setting rulings that have helped shape the law for the benefit of those harmed by dangerous drugs and medical devices. He is currently leading the firm’s Gardasil cases.

What is Lawdragon?

Lawdragon is one of the country’s most trusted and popular legal media companies. It reports on important legal news stories and legislative updates. Lawdragon also reviews and appraises attorneys that it believes to be at the top of their practices, who are then curated in its annual 500 Leading Plaintiff Consumer Lawyers list. Peer nominations are used to begin this process, which helps keep it open to any practicing attorney.

In its 2022 edition announcement, Lawdragon said this about the attorneys who made the list: “From the opioid epidemic to toxic substances and defective products, truck accidents to wildfires and sexual abuse, these are the lawyers who stand on the front line in individual lawsuits and class actions seeking justice. They relish their role of underdog, taking on the toughest cases and typically only getting paid if they win. Talk about heroes.”

Elevated & Award-Winning Legal Advocacy

Baum Hedlund Aristei & Goldman is a nationwide plaintiffs law firm that is known for litigating high-stakes cases against major corporations, particularly in the commercial transportation, pharmaceutical drug, and consumer product industries. Since 1973, the firm has won more than $4 billion in verdicts and settlements for clients across a wide range of practice areas. Many thousands of people have trusted Baum Hedlund to represent their interests in complex cases. No matter the corporate defendant, Baum Hedlund has the experience and resources needed to prevail.

If you have been injured and need legal assistance, contact our firm online today. Inquiring clients can also dial (855) 948-5098 to connect with our headquarters in Los Angeles. We take cases throughout the nation.

Categories

Contact Us Today

No Fees Unless We Win
  • Please enter your first name.
  • Please enter your last name.
  • Please enter your phone number.
    This isn't a valid phone number.
  • Please enter your email address.
    This isn't a valid email address.
  • Please make a selection.
  • Please enter a message.